Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For BRZE
Valuation Bad
0%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -5.65 1.96 2.08
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 62.26 -0.25 -0.65
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -4.00 4.33 4.51
Cash -0.65 4.83 4.86
Capex -5.68 -0.08 -0.07
Free Cash Flow 216.14 0.11 -0.04
Revenue 1.15 1.34 1.33
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -0.09 0.67 0.67
Operating Margin -25.31 -0.30 -0.24
ROA -25.24 -0.04 -0.03
ROE -28.39 -0.08 -0.06
ROIC -32.39 -0.08 -0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of BRZE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of BRZE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of BRZE is permitted for members.